Why is Sampre Nutrition falling/rising?

Jul 17 2025 10:20 PM IST
share
Share Via
As of 17-Jul, Sampre Nutritions Ltd is currently priced at 44.34, reflecting a recent short-term gain of 50.71% over 21 days, but faces significant financial challenges including operating losses and a high Debt to EBITDA ratio. Despite outperforming the Sensex recently, its long-term performance is weak with a year-to-date return of -30.39%, indicating caution for investors.
As of 17-Jul, Sampre Nutritions Ltd is experiencing a price increase, currently at 44.34, with a change of 0.86, reflecting a rise of 1.98%. The stock has shown strong performance recently, gaining 50.71% over the last 21 days and outperforming its sector by 1.88% today. However, despite this short-term gain, the company faces significant challenges, including operating losses and a high Debt to EBITDA ratio of 5.01 times, which indicates a low ability to service debt. The company's return on equity is also low at 1.71%, and it has reported negative earnings, with a PAT of Rs -7.35 cr, marking a drastic decline compared to previous quarters. This combination of positive short-term performance and underlying financial weaknesses contributes to a complex outlook for the stock.
In the broader market context, while Sampre Nutritions has outperformed the Sensex in the short term with a 10.02% return over the past week compared to the benchmark's decline of 1.12%, it has significantly underperformed over longer periods, with a year-to-date return of -30.39% against the Sensex's gain of 5.27%. This stark contrast highlights the stock's volatility and the risks associated with its current financial health, as it has generated negative returns of -36.11% over the past year while the broader market has shown modest gains. The stock's recent rise may be attributed to short-term trading dynamics, but the long-term fundamentals remain weak, suggesting caution for investors.
{{stockdata.stock.stock_name.value}} Live

{{stockdata.stock.price.value}} {{stockdata.stock.price_difference.value}} ({{stockdata.stock.price_percentage.value}}%)

{{stockdata.stock.date.value}} | BSE+NSE Vol: {{stockdata.index_name}} Vol: {{stockdata.stock.bse_nse_vol.value}} ({{stockdata.stock.bse_nse_vol_per.value}}%)


Our weekly and monthly stock recommendations are here
Loading...
{{!sm.blur ? sm.comp_name : ''}}
Industry
{{sm.old_ind_name }}
Market Cap
{{sm.mcapsizerank }}
Date of Entry
{{sm.date }}
Entry Price
Target Price
{{sm.target_price }} ({{sm.performance_target }}%)
Holding Duration
{{sm.target_duration }}
Last 1 Year Return
{{sm.performance_1y}}%
{{sm.comp_name}} price as on {{sm.todays_date}}
{{sm.price_as_on}} ({{sm.performance}}%)
Industry
{{sm.old_ind_name}}
Market Cap
{{sm.mcapsizerank}}
Date of Entry
{{sm.date}}
Entry Price
{{sm.opening_price}}
Last 1 Year Return
{{sm.performance_1y}}%
Related News
Sampre Nutritions Ltd is Rated Strong Sell
Mar 31 2026 10:10 AM IST
share
Share Via
Sampre Nutritions Ltd is Rated Sell
Mar 12 2026 10:10 AM IST
share
Share Via
Sampre Nutritions Ltd is Rated Sell
Feb 28 2026 10:10 AM IST
share
Share Via
Sampre Nutritions Ltd is Rated Sell
Feb 17 2026 10:10 AM IST
share
Share Via